Followers | 251 |
Posts | 13641 |
Boards Moderated | 0 |
Alias Born | 05/19/2015 |
Tuesday, September 06, 2022 8:14:17 PM
So others are not misinformed!
On July 19, 2022 Regen Biopharma, Inc. (the “Company”) issued 54,514,492 common shares (“Shares”) to Coventry Enterprises LLC in satisfaction of $180,552 of convertible indebtedness. The principal balance and accrued interest payable remaining on the $1,500,000 promissory note issued to Coventry Enterprises LLC are both $0 as of July 19,2022.
https://docoh.com/search?q=0001589150
On no recognized income Zero debt!
The Company recognized Net Income of $66,958,167 during the quarter ended June 30, 2022
There’s a big difference between Derivative Liability and debt.
It looks like the recognized $66 million Net income took care of the very small debt and Derivative Liability LoL!
LOL SLAM DUNK! Outdated MISINFORMATION PROVEN WRONG AGAIN!
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM